Synergistic effects of streptolysin S and streptococcal pyrogenic exotoxin B on the mouse model of group A streptococcal infection

Medical Microbiology and Immunology

Volumn 201, Issue 3, 2012, Pages 357-369

  Hung, Chih Hsin ^a   Tsao, Nina ^a   Zeng, Yi Fang ^a   Lu, Shiou Ling ^b   Chiang Ni, Chuan ^b   Lin, Yee Shin ^b   Wu, Jiunn Jong ^b   Kuo, Chih Feng ^a  

^a I SHOU UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Group A streptococcus; Streptococcal pyrogenic exotoxin B; Streptolysin S

Indexed keywords

BACTERIAL TOXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; STREPTOCOCCAL PYROGENIC EXOTOXIN B; STREPTOLYSIN S; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL GENE; CELL KILLING; CONTROLLED STUDY; EXUDATE; GENE EXPRESSION REGULATION; GROUP A STREPTOCOCCAL INFECTION; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; MACROPHAGE; MALE; MOLECULAR PATHOLOGY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SAGB GENE; SKIN DEFECT; SPEB GENE; STREPTOCOCCUS GROUP A; TISSUE INJURY; TOXIN ANALYSIS; WILD TYPE;

ANIMALS; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; EXOTOXINS; HUMANS; IMMUNE EVASION; MALE; MICE; MICE, INBRED BALB C; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; STREPTOLYSINS; VIRULENCE; VIRULENCE FACTORS;

EID: 84864336929     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-012-0241-6     Document Type: Article

References (48)

1. Cone LA, Woodard DR, Schlievert PM, Tomory GS (1987) Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 317:146-149
2. Spencer RC (1995) Invasive streptococci. Eur J Clin Microbiol Infect Dis 14:S26-S32
3. Ashbaugh CD, Warren HB, Carey VJ, Wessels MR (1998) Molecular analysis of the role of the group A streptococcalcysteine protease, hyaluronic acid capsule, and M protein in amurine model of human invasive soft-tissue infection. J Clin Invest 102:550-560
4. Carlsson F, Sandin C, Lindahl G (2005) Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol Micribiol 56:28-39
5. Fernie-King BA, Seilly DJ, Willers C, Wurzner R, Davies A, Lachmann PJ (2001) Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes. Immunology 103:390-398
6. Ji Y, McLandsborough L, Kondagunta A, Cleary PP (1996) C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun 64:503-510
7. Wessels MR, Moses AE, Goldberg JB, DiCesare TJ (1991) Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci USA 88:8317-8321
8. Collin M, Olsen A (2001) Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 69:7187-7189
9. Kuo CF, Wu JJ, Lin KY, Tsai PJ, Lee SC, Jin YT, Lei HY, Lin YS (1998) Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun 66:3931-3935
10. Lukomski S, Montgomery CA, Rurangirwa J, Geske RS, Barrish JP, Adams GJ, Musser JM (1999) Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect Immun 67:1779-1788
11. Sumby P, Barbian KD, Gardner DJ, Whitney AR, Welty DM, Long RD, Bailey JR, Parnell MJ, Hoe NP, Adams GG, DeLeo FR, Musser JM (2005) Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci USA 102:1679-1684
12. von Pawel-Rammingen U, Johansson BP, Bjorck L (2002) IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J 21:1607-1615
13. Kuo CF, Luo YH, Lin HY, Huang KJ, Wu JJ, Lei HY, Lin MT, Chuang WJ, Liu CC, Jin YT, Lin YS (2004) Histopathologic changes in kidney and liver correlate with streptococcal pyrogenicexotoxin B production in the mouse model of group A streptococcal infection. Microb Pathog 36:273-285
14. Lukomski S, Burns EH Jr, Wyde PR, Podbielski A, Rurangirwa J, Moore-Poveda DK, Musser JM (1998) Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect Immun 66:771-776
15. Svensson MD, Scaramuzzino DA, Sjobring U, Olsen A, Frank C, Bessen DE (2000) Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci. Mol Microbiol 38:242-253
16. Aziz RK, Kansal R, Aronow BJ, Taylor WL, Rowe SL, Kubal M, Chhatwal GS, Walker MJ, Kotb M (2010) Microevolution of group A streptococci in vivo: capturing regulatory networks engaged in sociomicrobiology, niche adaptation, and hypervirulence.PLoS ONE 5:e9798
17. Kuo CF, Lin YS, Chuang WJ, Wu JJ, Tsao N (2008) Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis. Infect Immun 76:1163-1169
18. Terao Y, Mori Y, Yamaguchi M, Shimizu Y, Ooe K, Hamada S, Kawabata S (2008) Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity. J Biol Chem 283:6253-6260
19. Kapur V, Topouzis S, Majesky MW, Li LL, Hamrick MR, Hamill RJ, Patti JM, Musser JM (1993) A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog 15:327-346
20. Herwald H, Collin M, Muller-Esterl W, Bjorck L (1996) Streptococcalcysteine proteinase releases kinins: a novel virulence mechanism. J Exp Med 184:665-673
21. Burns EH Jr, Marciel AM, Musser JM (1996) Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Infect Immun 64:4744-4750
22. Kapur V, Majesky MW, Li LL, Black RA, Musser JM (1993) Cleavage of interleukin 1β (IL-1β) precursor to produce active IL-1b by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci USA 90:7676-7680
23. Wolf BB, Gibson CA, Kapur V, Hussaini IM, Musser JM, Gonias SL (1994) Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases anactive fragment of the receptor from the cell surface. J Biol Chem 269:30682-30687
24. Betschel SD, Borgia SM, Barg NL, Low DE, De Azavedo JC (1998) Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun 66:1671-1679
25. Miyoshi-Akiyama T, Takamatsu D, Koyanagi M, Zhao J, Imanishi K, Uchiyama T (2005) Cytocidal effect of Streptococcus pyogenes on mouse neutrophils in vivo and the critical role of streptolysin S. J Infect Dis 192:107-116
26. Nizet V, Beall B, Bast DJ, Datta V, Kilburn L, Low DE, De Azayedo JC (2000) Genetic locus for streptolysin S production by group A streptococcus. Infect Immun 68:4245-4254
27. Fontaine MC, Lee JJ, Kehoe MA (2003) Combined contribution of streptolysin O and streptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo. Infect Immun 71:3857-3865
28. Sierig G, Cywes C, Wessels MR, Ashbaugh CD (2003) Cytotoxic effects of streptolysin O and streptolysin S enhance the virulence of poorly encapsulated group A streptococci. Infect Immun 71:446-455
29. Datta V, Myskowski SM, Kwinn LA, Chiem DN, Varki N, Kansal RG, Kotb M, Nizet V (2005) Mutational analysis of thegroup A streptococcal operon encoding streptolysin S and its virulence role in invasive infection. Mol Microbiol 56:681-695
30. Mangold M, Siller M, Roppenser B, Vlaminckx BJ, Penfound TA, Klein R, Novak R, Charpentier E (2004) Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule. Mol Microbiol 53:1515-1527
31. Tsai PJ, Kuo CF, Lin KY, Lin YS, Chen FF, Wang JR, Wu JJ (1998) Effect of group A streptococcal cysteine protease on invasion of epithelial cells. Infect Immun 66:1460-1466
32. Wang Y, Taylor DE (1990) Chloramphenicol resistance in Campylobacter coli: nucleotide sequence, expression, and cloning vector construction. Gene 94:23-28
33. Saouda M, Conran P, Boyle MDP (2001) Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by otherStreptococcus pyogenes products. J Infect Dis 184:723-731
34. Shanley TP, Schrier D, Kapur V, Musser JM, Ward PA (1996)Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect Immun 64:870-877
35. Lyon WR, Caparon MG (2004) Role of serine protease HtrA (DegP) of Streptococcus pyogenes in the biogenesis of virulence factors SpeB and the hemolysin strptolysin S. Infect Immun 72:1618-1625
36. Egesten A, Olin AI, Linge HM, Yadav M, Mörgelin M, Karlsson A, Collin M (2009) SpeB of Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human chemokines. PLoS ONE 4:e4769
37. Davis JM, Ramakrishnan L (2009) The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell136:37-49
38. Kage H, Takaya A, Ohya M, Yamamoto T (2008) Coordinated regulation of expression of Salmonella pathogenicity island 1 andflagellar type III secretion systems by ATP-dependent ClpXP protease. J Bacteriol 190:2470-2478
39. Tapfer H, Liigant A, Simovart HE, Põldoja E, Kokk K, Naaber P, Talvik R (2003) Dissemination of bacteria in multiple organs associated with apoptosis and macrophage activity in different stages of experimental sepsis. Scand J Surg 92:163-170
40. Olsen RJ, Sitkiewicz I, Ayeras AA, Gonulal VE, Cantu C, Beres SB, Green NM, Lei B, Humbird T, Greaver J, Chang E, Ragasa WP, Montgomery CA, Cartwright J Jr, McGeer A, Low DE, Whitney AR, Cagle PT, Blasdel TL, DeLeo FR, Musser JM (2010) Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci USA 107:888-893
41. Hollands A, Aziz RK, Kansal R, Kotb M, Nizet V, Walker MJ (2008) A naturally occurring mutation in ropB suppresses SpeB expression and reduces M1T1 group A streptococcal systemic virulence. PLoS ONE 3:1-7
42. Meinert Niclasen L, Olsen JG, Dagil R, Qing Z, Sørensen OE, Kragelund BB (2011) Streptococcal pyogenic exotoxin B (SpeB) boosts the contact system via binding of a-1 antitrypsin. Biochem J 434:123-132
43. Carroll RK, Musser JM (2011) From transcription to activation: how group A Streptococcus, the flesh-eating pathogen, regulates SpeB cysteine protease production. Mol Microbiol 81:588-601
44. Sumitomo T, Nakata M, Higashino M, Jin Y, Terao Y, Fujinaga Y, Kawabata S (2011) Streptolysin S contributes to group A streptococcal translocation across an epithelial barrier. J Biol Chem 286:2750-2761
45. Norrby-Teglund A, Pauksens K, Norgren M, Holm SE (1995) Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infection. Scand J Infect Dis 27:125-130
46. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL (1996) Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 64:4733-4738
47. LeBlanc DJ, Lee LN, Abu-Al-Jaibat A (1992) Molecular, genetic, and functional analysis of the basic replicon of pVA380-1, a plasmid of oral streptococcal origin. Plasmid 28:130-145
48. O'Sullivan DJ, Klaenhammer TR (1993) High-and low-copynumber Lactococcus shuttle cloning vectors with features for clone screening. Gene 137:227-231